Challenges in secondary prevention after acute myocardial infarction: A call for action
- 10 March 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 6 (4) , 299-310
Abstract
Worldwide, each year more than 7 million people experience myocardial infarction, in which one-year mortality rates are now in the range of 10%, but vary with patient characteristics. The consequences are even more dramatic: among patients who survive, 20% suffer a second cardiovascular event in the first year and approximately 50% of major coronary events occur in those with a previous hospital discharge diagnosis of ischaemic heart disease. The people behind these numbers spur this call for action. Prevention after myocardial infarction is crucial to reduce risk and suffering. Evidence-based interventions include optimal medical treatment with anti-platelets and statins, achievement of blood pressure, lipid and blood glucose targets, and appropriate lifestyle changes. The European Society of Cardiology and its constituent bodies are determined to embrace this challenge by developing a consensus document in which the existing gaps for secondary prevention strategies are reviewed. Effective interventions in relation to the patients, healthcare providers and healthcare systems are proposed and discussed. Finally, innovative strategies in hospital as well as in outpatient and long-term settings are endorsed.Keywords
This publication has 61 references indexed in Scilit:
- Do practitioners and friends support patients with coronary heart disease in lifestyle change? a qualitative studyBMC Family Practice, 2013
- RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean DietNew England Journal of Medicine, 2013
- ACHTUNG-Rule: a new and improved model for prognostic assessment in myocardial infarctionEuropean Heart Journal: Acute Cardiovascular Care, 2012
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)European Heart Journal, 2012
- Rivaroxaban in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory SurveyEuropean Journal of Preventive Cardiology, 2010
- Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease PatientsJACC, 2009
- Reengineering Hospital Discharge: A Protocol to Improve Patient Safety, Reduce Costs, and Boost Patient SatisfactionAmerican Journal of Medical Quality, 2009
- Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trialThe Lancet, 2008
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999